RenovoRx, Inc. (RNXT) Earnings History
Annual and quarterly earnings data from 2019 to 2024
Loading earnings history...
RNXT EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
RNXT Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 100.0% | -25511.6% | -20497.7% |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export RNXT earnings history in CSV or JSON format
Free sign-in required to download data
RenovoRx, Inc. (RNXT) Earnings Overview
As of May 8, 2026, RenovoRx, Inc. (RNXT) reported trailing twelve-month net income of -$11M, reflecting +26.0% year-over-year growth. The company earned $-0.30 per diluted share over the past four quarters, with a net profit margin of -20497.7%.
Looking at the long-term picture, RNXT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$4M in fiscal 2020.
RenovoRx, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NKTR (-$164M net income, -297.1% margin), CRIS (-$8M net income, -80.3% margin), TPVG (-$12M net income, 50.6% margin), RNXT has room to improve margins relative to the peer group. Compare RNXT vs NKTR →
RNXT Earnings vs Peers
Earnings metrics vs comparable public companies
RNXT Historical Earnings Data (2019–2024)
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$9M | +13.9% | -$11M | $-0.37 | -20497.7% | -25511.6% |
| 2023 | -$10M | -3.5% | -$11M | $-0.50 | - | - |
| 2022 | -$10M | -56.4% | -$10M | $-0.54 | - | - |
| 2021 | -$6M | -66.5% | -$6M | $-0.40 | - | - |
| 2020 | -$4M | +1.1% | -$3M | $-0.25 | - | - |
| 2019 | -$4M | - | -$4M | $-0.22 | - | - |
See RNXT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RNXT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RNXT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRNXT — Frequently Asked Questions
Quick answers to the most common questions about buying RNXT stock.
Is RNXT growing earnings?
RNXT EPS is $-0.30, with earnings growth accelerating to +26.0%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-11M.
What are RNXT's profit margins?
RenovoRx, Inc. net margin is -20497.7%, with operating margin at -25511.6%. Below-average margins reflect competitive or cost pressures.
How consistent are RNXT's earnings?
RNXT earnings data spans 2019-2024. The accelerating earnings trend is +26.0% YoY. Historical data enables comparison across business cycles.